GlaxoSmithKline

The May/June 2016 issue of The Research Advocate is now online . Highlights from this month include: Research!America board members Bill Hait, M.D. , Janssen Research & Development, and Keith Yamamoto, Ph.D ., University of California, San Francisco, will be discussing the concept of immorbidity on June 8 at the BIO International Convention. “Medical Research: The Right Prescription for Economic Growth” will be taking place June 6 on the campus of Northeast Ohio Medical University (NEOMED) in Rootstown, Ohio. A federal policy update on the Senate Innovations initiative, the current status of appropriations for NIH, NSF and FDA, and the recent announcement of the new AHRQ director. Learn...
A lab-turned-hospital for mice in Boston is helping researchers understand cancer in humans. Jessica Rinaldi for The New York Times Maybe this sounds like the opening line to one of those wasteful-spending reports, but it’€™s not. And the results ’€” while still a long way from producing a treatment ’€” have allowed researchers to gain insight into the links between cancer and a handful of mutated genes. New York Times reporter Gina Kolkata describes the ’€œhospital’€ at Beth Israel Deaconess Medical Center: imaging devices writ small with a dedicated pharmacy and clinical lab. She follows researchers that are looking into prostate cancer. Mice are injected with a few rogue genes, and...

Sidebar Quote

You can change the image of things to come. But you can’t do it sitting on your hands … The science community should reach out to Congress and build bridges.
The Honorable John E. Porter